WalkLung Trial
Cross-source consensus on WalkLung Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Risks & contraindications
Other
Highlighted claims
- WalkLung is a multicentre parallel-group randomised controlled trial evaluating a home-based walking and education programme after lung cancer surgery. — Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial
- The intervention targets the first four weeks after hospital discharge. — Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial
- The trial is conducted in China and enrolls patients after lung cancer surgery before discharge. — Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial
- Outcome assessors and statisticians are blinded, but participants and treating clinicians are not. — Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial
- Randomisation is centralised, stratified by centre, and concealed from the clinical team. — Effect of home-based walking exercise and education on early functional recovery after lung cancer surgery: protocol for the WalkLung multicentre randomised controlled trial